Characterization of the molecular mechanisms that govern anti-Mullerian hormone synthesis and activity

被引:5
作者
Stocker, William A. [1 ,5 ]
Howard, James A. [2 ]
Maskey, Shreya [1 ]
Luan, Haitong [1 ]
Harrison, Sophie G. [1 ]
Hart, Kaitlin N. [2 ]
Hok, Lucija [3 ]
Thompson, Thomas B. [3 ]
Walton, Kelly L. [1 ,4 ]
Harrison, Craig A. [1 ,5 ]
机构
[1] Monash Univ, Monash Biomed Discovery Inst, Dept Physiol, Clayton, Vic, Australia
[2] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH USA
[3] Univ Cincinnati, Dept Mol & Cellular Biosci, Cincinnati, OH USA
[4] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia
[5] Monash Univ, Monash Biomed Discovery Inst, Dept Physiol, Clayton, Vic 3800, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
AMH; anti-Mullerian hormone; folliculogenesis; ovary; protein engineering; TGF-beta superfamily; INHIBITING SUBSTANCE; TGF-BETA; DUCT REGRESSION; GONADAL DEVELOPMENT; OVARIAN RESERVE; CELL LINE; GROWTH; RECEPTOR; EXPRESSION; PATHWAY;
D O I
10.1096/fj.202301335RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The roles of anti-M & uuml;llerian hormone (AMH) continue to expand, from its discovery as a critical factor in sex determination, through its identification as a regulator of ovarian folliculogenesis, its use in fertility clinics as a measure of ovarian reserve, and its emerging role in hypothalamic-pituitary function. In light of these actions, AMH is considered an attractive therapeutic target to address diverse reproductive needs, including fertility preservation. Here, we set out to characterize the molecular mechanisms that govern AMH synthesis and activity. First, we enhanced the processing of the AMH precursor to >90% by introducing more efficient proprotein convertase cleavage sites (RKKR or ISSRKKRSVSS [SCUT]). Importantly, enhanced processing corresponded with a dramatic increase in secreted AMH activity. Next, based on species differences across the AMH type II receptor-binding interface, we generated a series of human AMH variants and assessed bioactivity. AMH(SCUT) potency (EC50 4 ng/mL) was increased 5- or 10-fold by incorporating Gln(484)Met/Leu(535)Thr (EC50 0.8 ng/mL) or Gln(484)Met/Gly(533)Ser (EC50 0.4 ng/mL) mutations, respectively. Furthermore, the Gln(484)Met/Leu(535)Thr double mutant displayed enhanced efficacy, relative to AMH(SCUT). Finally, we identified residues within the wrist pre-helix of AMH (Trp(494), Gln(496), Ser(497), and Asp(498)) that likely mediate type I receptor binding. Mutagenesis of these residues generated gain- (Trp(494)Phe or Gln(496)Leu) or loss- (Ser(497)Ala) of function AMH variants. Surprisingly, combining activating type I and type II receptor mutations only led to modest additive increases in AMH potency/efficacy. Our study is the first to characterize AMH residues involved in type I receptor binding and suggests a step-wise receptor-complex assembly mechanism, in which enhancement in the affinity of the ligand for either receptor can increase AMH activity beyond the natural level.
引用
收藏
页数:18
相关论文
共 70 条
[1]   Species Differences in the Expression and Activity of Bone Morphogenetic Protein 15 [J].
Al-Musawi, Sara L. ;
Walton, Kelly L. ;
Heath, Derek ;
Simpson, Courtney M. ;
Harrison, Craig A. .
ENDOCRINOLOGY, 2013, 154 (02) :888-899
[2]   Structure of the ternary signaling complex of a TGF-β superfamily member [J].
Allendorph, George P. ;
Vale, Wylie W. ;
Choe, Senyon .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) :7643-7648
[3]   Role of type I receptors for anti-Mullerian hormone in the SMAT-1 Sertoli cell line [J].
Belville, C ;
Jamin, SP ;
Picard, JY ;
Josso, N ;
di Clemente, N .
ONCOGENE, 2005, 24 (31) :4984-4992
[4]  
Case D. A., 2018, AMBER 2018
[5]  
Cate RL., 2022, J Biol Chem, V298, P19
[6]   Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking [J].
Chen, Fu ;
Liu, Hui ;
Sun, Huiyong ;
Pan, Peichen ;
Li, Youyong ;
Li, Dan ;
Hou, Tingjun .
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2016, 18 (32) :22129-22139
[7]   Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression [J].
Clarke, TR ;
Hoshiya, Y ;
Yi, SE ;
Liu, XH ;
Lyons, KM ;
Donahoe, PK .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (06) :946-959
[8]   Regulation of TGFβ and related signals by precursor processing [J].
Constam, Daniel B. .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 32 :85-97
[9]   Structure of the human myostatin precursor and determinants of growth factor latency [J].
Cotton, Thomas R. ;
Fischer, Gerhard ;
Wang, Xuelu ;
McCoy, Jason C. ;
Czepnik, Magdalena ;
Thompson, Thomas B. ;
Hyvonen, Marko .
EMBO JOURNAL, 2018, 37 (03) :367-383
[10]   The physiology and clinical utility of anti-Mllerian hormone in women [J].
Dewailly, Didier ;
Andersen, Claus Yding ;
Balen, Adam ;
Broekmans, Frank ;
Dilaver, Nafi ;
Fanchin, Renato ;
Griesinger, Georg ;
Kelsey, Tom W. ;
La Marca, Antonio ;
Lambalk, Cornelius ;
Mason, Helen ;
Nelson, Scott M. ;
Visser, Jenny A. ;
Wallace, W. Hamish ;
Anderson, Richard A. .
HUMAN REPRODUCTION UPDATE, 2014, 20 (03) :370-385